Author

W. Murphy

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metagenomics· 1 Organism:mouse· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Dev· 1 shared A. I. Caplan· 1 shared A. Osme· 1 shared A. Psaltis· 1 shared B. D. Johnson· 1 shared C. Soto· 1 shared E. Smith· 1 shared F. Cominelli· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Dev

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A comparison between full-length 16S rRNA Oxford Nanopore sequencing and Illumina V3-V4 16S rRNA sequencing in head and neck cancer tissues

K. Yeo, J. Connell, G. Bouras, E. Smith, W. Murphy, J.-C. Hodge, S. Krishnan, P.-J. Wormald, R. Valentine, A. Psaltis, S. Vreugde, K. Fenix

This study compares full-length 16S rRNA sequencing using Oxford Nanopore Technology (FL-ONT) with Illumina V3-V4 short-read sequencing in head and neck cancer tissues, finding FL-ONT provides better resolution at lower taxonomic levels.

bioRxiv · Mar 8, 2024Microbiology

Mesenchymal stem cells ameliorate inflammation in an experimental model of Crohn's disease via the mesentery

M. Dave, A. Dev, R. A. Somoza, N. Zhao, S. Viswanath, P. R. Mina, P. Chirra, V. C. Obmann, G. H. Mahabeleshwar, P. Menghini, B. D. Johnson, J. A. Nolta, C. Soto, A. Osme, L. T. Khuat, , F. Cominelli

This study shows that mesenchymal stem cells (MSCs) reduce inflammation in a mouse model of Crohn's disease by modulating T cells and macrophages in the mesentery, with long-term effects through macrophage reprogramming.

bioRxiv · May 22, 2023 · PreprintImmunology